MedTrace Logo

Early Interventional Treatment for Cancer Pain

NCT05366413 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-04-16

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to evaluate how feasible and beneficial it is to refer patients with cancer pain to a doctor who specializes in pain management, including procedures to relieve pain, and whether this is helpful to patients with pain related to their cancer.

Conditions

  • Cancer Pain

Interventions

OTHER

Early Referral

Directing a patient for a pain specialist consult earlier than standardly occurs.

OTHER

Pain Management Strategies

Specialized plan with procedures to ease pain

Sponsors & Collaborators

Principal Investigators

  • Andrea Enzinger, MD · Dana-Farber Cancer Institute

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-02
Primary Completion
2024-02-26
Completion
2024-10-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05366413 on ClinicalTrials.gov